-
(3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
-
ChemBase ID:
154007
-
Molecular Formular:
C27H35ClN2O7
-
Molecular Mass:
535.029
-
Monoisotopic Mass:
534.21327915
-
SMILES and InChIs
SMILES:
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(c(cc2C[C@H]1C(=O)O)OC)OC.Cl
Canonical SMILES:
CCOC(=O)[C@@H](N[C@H](C(=O)N1Cc2cc(OC)c(cc2C[C@H]1C(=O)O)OC)C)CCc1ccccc1.Cl
InChI:
InChI=1S/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22-;/m0./s1
InChIKey:
JXRAXHBVZQZSIC-JKVLGAQCSA-N
-
Cite this record
CBID:154007 http://www.chembase.cn/molecule-154007.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid hydrochloride
|
Moexipril hydrochloride
|
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid 盐酸盐
|
Moexipril 盐酸盐
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
3.462318
|
H Acceptors
|
7
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.1609751
|
LogD (pH = 7.4)
|
-0.08144003
|
Log P
|
1.5021217
|
Molar Refractivity
|
132.8822 cm3
|
Polarizability
|
52.210068 Å3
|
Polar Surface Area
|
114.4 Å2
|
Rotatable Bonds
|
12
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
M0821
|
Biochem/physiol Actions Moexipril is an ACE-Inhibitor; Antihypertensive; Unlike other ACE inhibitors, prolongs QT interval leading to torsades de pointes and cardiad arrhythmia; |
PATENTS
PATENTS
PubChem Patent
Google Patent